Sign In
Buy ABT
$93.24
+2.73 (+3.02%)
At Close: Jun 25, 2026
Compared to Estimates, Abbott (ABT) Q1 Earnings: A Look at Key Metrics
10:30am, Wednesday, 16'th Apr 2025
While the top- and bottom-line numbers for Abbott (ABT) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to
Nasdaq Down Over 2%; Abbott Laboratories Posts Upbeat Earnings
10:06am, Wednesday, 16'th Apr 2025
U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 2% on Wednesday.
Abbott (ABT) Q1 Earnings Beat Estimates
09:45am, Wednesday, 16'th Apr 2025
Abbott (ABT) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $0.98 per share a year ago.
Abbott Laboratories Dips As Sales Come In Light Despite Profit Beat
08:59am, Wednesday, 16'th Apr 2025
Abbott stock slipped early Wednesday after the health giant reported light first-quarter sales, though profit beat expectations.
Abbott Labs Profit Jumps on Gains in Nutrition, Medical Devices
08:23am, Wednesday, 16'th Apr 2025
Abbott Labs recorded higher earnings and revenue in the first quarter as strong demand for its nutritional products and medical devices offset weakness in other segments.
Abbott Laboratories Stock Slips as First-Quarter Sales Miss Expectations
08:14am, Wednesday, 16'th Apr 2025
Abbott Labs posts first-quarter adjusted profit that topped analysts' estimates.
Abbott beats quarterly profit estimate on strong medical device demand
07:33am, Wednesday, 16'th Apr 2025
Abbott Laboratories beat Wall Street estimates for first-quarter profit on Wednesday, buoyed by strong demand for diabetes care and other medical devices.
Abbott Reports First-Quarter 2025 Results and Reaffirms Full-Year Guidance
07:30am, Wednesday, 16'th Apr 2025
First-quarter GAAP diluted EPS of $0.76; adjusted diluted EPS of $1.09 First-quarter reported sales growth of 4.0 percent; organic sales growth of 6.9 percent or 8.3 percent when excluding COVID-19 te
How To Earn $500 A Month From Abbott Laboratories Stock Ahead Of Q1 Earnings
08:35am, Tuesday, 15'th Apr 2025
Abbott Laboratories ABT will release its first-quarter earnings results before the opening bell on Wednesday, April 16.
Tap Into the Silver Economy Boom With These Aging Demographics Stocks
04:00pm, Monday, 14'th Apr 2025
The global demographic shift is reshaping healthcare demand, driving long-term investment in pharmaceuticals, medical devices, home care and digital health.
Seeking Clues to Abbott (ABT) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
10:20am, Friday, 11'th Apr 2025
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Abbott (ABT), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quar
Abbott's Q1 Earnings Coming Up, Medical Devices Arm in Focus
09:55am, Thursday, 10'th Apr 2025
ABT's Structural Heart, Rhythm Management and Neuromodulation businesses are likely to have driven its first-quarter 2025 performance.
Will Trump Tariffs Make or Break Healthcare Space? 3 Stocks to Rely On
04:00pm, Wednesday, 09'th Apr 2025
Investors looking to maintain exposure to healthcare can invest in large-cap U.S.-based companies like UHS, BMRN and ABT.
Abbott (ABT) Earnings Expected to Grow: Should You Buy?
11:06am, Wednesday, 09'th Apr 2025
Abbott (ABT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
10:00am, Wednesday, 09'th Apr 2025
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
